Den Broek Richard Van's Net Worth
$10.3 Million
Who is Den Broek Richard Van?
Den Broek Richard Van has an estimated net worth of $10.3 Million. This is based on reported shares across multiple companies, which include Celldex Therapeutics, Inc., PhaseBio Pharmaceuticals Inc, Pulse Biosciences, Inc., STRATEGIC DIAGNOSTICS INC/DE/, RESPONSE GENETICS INC, and PHARMACYCLICS INC.
SEC CIK
Den Broek Richard Van's CIK is 0001431872
Past Insider Trading and Trends
2010 was Den Broek Richard Van's most active year for acquiring shares with 10 total transactions. Den Broek Richard Van's most active month to acquire stocks was the month of April. 2015 was Den Broek Richard Van's most active year for disposing of shares, totalling 29 transactions. Den Broek Richard Van's most active month to dispose stocks was the month of April. 2008 saw Den Broek Richard Van paying a total of $59,518.54 for 31,751 shares, this is the most they've acquired in one year. In 2015 Den Broek Richard Van cashed out on 100,522 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $44
InvestorDen Broek Richard Van owns 2,000 units of Common Stock, par value $0.001 per share which is worth $88,000.00 and 233,500 units of Common Stock which is worth $10,274,000.00. In the year 2014 Den Broek Richard Van filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.47% | 10K |
—
|
—
| 233.5K |
Jun 8
| |||
Form 4
| +325.00% | 6.5K |
—
|
—
| 8.5K |
Jun 10
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
InvestorDen Broek Richard Van used to own units in Common Stock but no longer holds any shares there. In the year 2019 Den Broek Richard Van filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.75K |
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
| No matching records found | |||||||||
Pulse Biosciences, Inc. (PLSE) Snapshot price: $17.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STRATEGIC DIAGNOSTICS INC/DE/ No price found
InvestorDen Broek Richard Van owns 28,230 units of Common. In the year 2008 Den Broek Richard Van acquired a total of 38,130 shares in STRATEGIC DIAGNOSTICS INC/DE/ at a cost of $18,612.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.72% | 2.5K |
—
|
—
| 28.23K |
Nov 22 - Jun 23
| |||
Form 4
| -100.00% | -75.00K |
$1.11 | -$83,602.50 |
0
|
Dec 24
| |||
Form 4
| -25.00% | -25.00K |
$1.11 | -$27,750.00 | 75K |
Dec 23
| |||
Form 4
| -28.52% | -39.90K |
$1.13 | -$45,087.00 | 100K |
Dec 19
| |||
Form 4
| -35.00% | -70.00K |
$1.12 | -$78,200.00 | 130K |
Dec 17 - Dec 18
| |||
Form 4
| +7.55% | 2.5K |
—
|
—
| 35.63K |
May 15
| |||
Form 4
| +8.16% | 2.5K |
—
|
—
| 33.13K |
May 17
| |||
Form 4
| +47.76% | 9.9K |
$1.88 | $18,612.00 | 30.63K |
Aug 23
| |||
Form 4
| +13.71% | 2.5K |
—
|
—
| 20.73K |
May 18
| |||
Form 4
| +15.89% | 2.5K |
—
|
—
| 18.23K |
May 12
| |||
Form 4
|
∞
| 15.73K |
—
|
—
| 15.73K |
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
| No matching records found | |||||||||
RESPONSE GENETICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
| +54.73% | 100K |
$1.50 | $150,000.00 | 282.7K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||